Maribavir Patent Expiration

Maribavir is Used for treating post-transplant cytomegalovirus (CMV) infection/disease refractory to other antiviral treatments in stem cell, kidney, or liver transplant recipients. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Livtencity on Nov 23, 2021.


Maribavir Patents

Given below is the list of patents protecting Maribavir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Livtencity US11684632 Maribavir isomers, compositions, methods of making and methods of using Jan 04, 2032 Takeda Pharms Usa


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳